Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer

por Brooks, Colin, Sheu, Tommy, Bridges, Kathleen, Mason, Kathy, Kuban, Deborah, Mathew, Paul, Meyn, Raymond
Publicado 2012

Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells

por Bridges, Kathleen A., Toniatti, Carlo, Buser, Carolyn A., Liu, Huifeng, Buchholz, Thomas A., Meyn, Raymond E.
Publicado 2014

MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells

por Bridges, Kathleen A., Chen, Xingxing, Liu, Huifeng, Rock, Crosby, Buchholz, Thomas A., Shumway, Stuart D., Skinner, Heath D., Meyn, Raymond E.
Publicado 2016

Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit

por Raju, Uma, Molkentine, David P, Valdecanas, David R, Deorukhkar, Amit, Mason, Kathryn A, Buchholz, Thomas A, Meyn, Raymond E, Ang, Kie-Kian, Skinner, Heath
Publicado 2015

Metabolic interrogation as a tool to optimize chemotherapeutic regimens

por Sandulache, Vlad C., Chen, Yunyun, Feng, Lei, William, William N., Skinner, Heath D., Myers, Jeffrey N., Meyn, Raymond E., Li, Jinzhong, Mijiti, Ainiwaer, Bankson, James A., Fuller, Clifton D., Konopleva, Marina Y., Lai, Stephen Y.
Publicado 2017

p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade

por Molkentine, David P., Molkentine, Jessica M., Bridges, Kathleen A., Valdecanas, David R., Dhawan, Annika, Bahri, Reshub, Hefner, Andrew J., Kumar, Manish, Yang, Liangpeng, Abdelhakiem, Mohamed, Pifer, Phillip M., Sandulache, Vlad, Sheth, Aakash, Beadle, Beth M., Thames, Howard D., Mason, Kathryn A., Pickering, Curtis R., Meyn, Raymond E., Skinner, Heath D.
Publicado 2022